Who owns APTEVO THERAPEUTICS INC?
- Ticker: APVO
- CUSIP Number: 03835l702
Tip: Access positions for across all investors
Analyze quarterly positions in Aptevo Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aptevo Therapeutics stock
Who bought or sold APTEVO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| GSA Capital Partners | 20k | $84k | 100% | Mar 2026 |
|
| Vanguard Group | 17k | $159k | 100% | Dec 2025 |
|
| Geode Capital Management | 13k | $57k | 100% | Mar 2026 |
|
| Vanguard Capital Management | 13k | $54k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 4.1k | $18k | 100% | Mar 2026 |
|
| UBS Group | 3.4k | $15k | 1926% | Mar 2026 |
|
| Advisor Group Holdings | 360.00 | $3.4k | 100% | Dec 2025 |
|
| SBI Securities | 109.00 | $465.004900 | 252% | Mar 2026 |
|
| Tower Research Capital | 92.00 | $868.001600 | 100% | Dec 2025 |
|
| FMR | 7.00 | $66.000200 | 100% | Dec 2025 |
|
| CWM | 6.00 | $0 | 100% | Dec 2025 |
|
| Danske Bank A/s | 1.00 | $4.000000 | 0% | Mar 2026 |
|
Who sold out of Aptevo Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tradewinds Capital Management | Dec 2025 | 13.00 | $117.999700 |